Moderna Shares Surge As Nasdaq-100 Re-Entry Looms
Moderna (MRNA) shares climbed approximately 7% on Monday, nearing $204, as investors anticipate the company's return to the Nasdaq-100 index later this week. The stock has seen a year-long surge.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.